Still, targeting HMGB1 or histone-deacetylase 11 by specific inhibitors could also provide an avenue to inhibit MDSC expansion and limit IL-10 production and thus enhance anti-tumour/infection immune responses. The gene discussed is HDAC11; the disease is neoplasm.